Purchase Order 75N92B21P00025

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $19,100 on September 5, 2018. The order covers custom Chromium single cell 3 library and gel bead kits, with delivery expected by September 28, 2018. Work is performed at the vendor's Pleasanton, California facility. The procurement used firm fixed price, commercial-item pricing with no small business set-aside.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $21,743.88 on April 9, 2021. The order is for Chromium Next GEM Single Cell kits (5' kit, 16 reactions and 48 reactions variants). Performance takes place in Pleasanton, California. The order was firm fixed price with no set-aside designation and completed on April 9, 2021.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $22,000.75 on July 14, 2020. Performance occurs in Pleasanton, California. The order procures Chromium single-cell V(D)J enrichment kits for human B cells, Chromium Next GEM single cell 5' library and gel bead kits, Chromium Next GEM chip G single cell kits, and single index kits. The order is firm fixed price with an ultimate completion date of July 14, 2020.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,067.00 on March 9, 2021, for Chromium Next GEM Single Cell Kits. Performance occurs in Pleasanton, California. The order is priced firm fixed and carries no set-aside designation. Ultimate completion is scheduled for March 9, 2021.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $24,084.00 on January 19, 2018. The order procures custom chromium single cell analysis reagents and consumables (3'/5' - 10X Genomics configuration). Performance occurs at 10X Genomics' facility in Pleasanton, California. The period of performance runs from January 19, 2018 through January 18, 2019, with ultimate completion targeted for February 28, 2018. The...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $185,142 on September 28, 2020 for reagents compatible with the Chromium Controller single cell platform.</p> <p>Work is performed at Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of October 30, 2020. No set-aside was used.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $21,600 on December 19, 2019. The order, which carries no set-aside designation, covers a platform supporting cell transcriptomics and cell-type identification and discovery. Work is performed at the vendor's facility in Pleasanton, California. The order is firm-fixed-price and concludes on December 26, 2019.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $59,999.00 on June 12, 2020. The order covers a 10X Genomics Chromium Controller single-cell instrument, equipment installation, and 12 months of warranty including parts and labor. Performance is located in Pleasanton, California, with an ultimate completion date of August 11, 2020. No small business set-aside was used. The award was flagged under the Coronavirus COVID-19...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $23,084.00 on December 12, 2017. The order covers custom single-cell RNA-sequencing services using 10X Genomics technology. Place of performance is Pleasanton, California. The period of performance runs from December 12, 2017 through December 11, 2018, with an ultimate completion date of January 31, 2018. The contract is firm fixed price with no set-aside category...

10X Genomics, Inc. is providing $24,999 worth of Chromium Next GEM Single Cell 3' Kit V3.1 products to the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases under a firm fixed price purchase order awarded on March 7, 2024. The place of performance is Pleasanton, California, with an expected completion date of March 6, 2025. The kit supports single cell RNA sequencing research efforts at the National Institute of Arthritis and Musculoskeletal...